Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2357 in Relapsed/Refractory CLL
NCT00792831Phase 2Terminated
- Sponsor
- Italfarmaco
- Start
- Feb 2008
- Primary completion
- Apr 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in chronic lymphocytic leukemia (CLL), sponsored by Italfarmaco. Started Feb 2008; status: terminated.
02
Drugs
givinostat
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00792831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792831.